SecSonar.com

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) is a Biotechnology company based in SG with a market capitalization of $6.7M. Revenue grew 3.3% year-over-year and free cash flow was negative at -$7.1M. This page tracks CUPR's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

SG · 15 employees · IPO Apr 10, 2025

Valuation

Valuation & price

$0.25 · as of May 26, 2026 · -99.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$73.68$37.83$1.98Jul 25Dec 25Jul 26Jul 7, 25$54.72Jul 9, 25$59.04Jul 11, 25$58.40Jul 15, 25$59.12Jul 17, 25$60.00Jul 21, 25$63.60Jul 23, 25$62.00Jul 25, 25$62.32Jul 29, 25$61.92Jul 31, 25$63.44Aug 4, 25$65.76Aug 6, 25$69.92Aug 11, 25$66.24Aug 13, 25$73.68Aug 15, 25$9.52Aug 19, 25$7.60Aug 21, 25$8.96Aug 25, 25$8.32Aug 27, 25$7.72Aug 29, 25$7.36Sep 3, 25$6.83Sep 5, 25$5.60Sep 9, 25$5.62Sep 11, 25$10.48Sep 16, 25$11.68Sep 18, 25$11.68Sep 22, 25$10.00Sep 24, 25$8.32Sep 26, 25$7.97Sep 30, 25$7.52Oct 2, 25$8.80Oct 6, 25$8.64Oct 8, 25$8.96Oct 10, 25$7.68Oct 14, 25$8.24Oct 16, 25$7.46Oct 21, 25$7.60Oct 23, 25$7.20Oct 27, 25$7.74Oct 29, 25$7.22Oct 31, 25$7.82Nov 4, 25$7.26Nov 6, 25$6.75Nov 10, 25$6.16Nov 12, 25$6.00Nov 14, 25$5.87Nov 18, 25$5.88Nov 20, 25$5.70Nov 25, 25$5.34Nov 28, 25$5.30Dec 2, 25$5.17Dec 4, 25$5.20Dec 8, 25$5.09Dec 10, 25$4.46Dec 12, 25$4.74Dec 16, 25$4.37Dec 18, 25$3.84Dec 22, 25$3.78Dec 24, 25$3.83Dec 29, 25$3.44Jan 2, 26$3.22Jan 6, 26$3.80Jan 8, 26$3.75Jan 12, 26$3.86Jan 14, 26$3.78Jan 16, 26$3.52Jan 21, 26$3.86Jan 23, 26$3.36Jan 27, 26$3.75Jan 29, 26$3.76Feb 2, 26$3.44Feb 4, 26$3.32Feb 9, 26$3.34Feb 11, 26$3.49Feb 13, 26$3.44Feb 18, 26$3.52Feb 20, 26$3.32Feb 24, 26$3.20Feb 26, 26$3.08Mar 2, 26$2.79Mar 4, 26$3.20Mar 6, 26$3.07Mar 10, 26$2.96Mar 12, 26$3.16Mar 17, 26$2.72Mar 19, 26$2.70Mar 23, 26$2.68Mar 25, 26$2.59Mar 27, 26$3.19Mar 31, 26$2.34Apr 2, 26$2.71Apr 7, 26$4.81Apr 9, 26$2.83Apr 13, 26$2.81Apr 15, 26$2.86Apr 17, 26$2.68Apr 22, 26$2.48Apr 24, 26$2.40Apr 28, 26$2.28Apr 30, 26$2.02May 4, 26$2.09May 6, 26$2.11May 8, 26$2.24May 12, 26$1.98May 14, 26$2.14May 18, 26$2.22May 20, 26$2.12May 22, 26$2.16May 28, 26$3.30Jun 1, 26$2.66Jun 3, 26$2.83Jun 5, 26$2.43Jun 9, 26$2.38Jun 11, 26$2.41Jun 15, 26$8.41Jun 17, 26$5.26Jun 22, 26$3.93Jun 24, 26$5.74Jun 26, 26$5.33Jul 2, 26$5.63
$1.9652-week range$75.20
Loading valuation history…

Fundamentals

Key fundamentals

$6.7M

Market cap

3.3%

Revenue growth (YoY)

-1.3%

Gross margin

-$7.1M

Free cash flow (USD)

-$2.6M

Net debt

Net cash position

-5.9%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2021 → 2025

FY 2021$58.5KFY 2022$56.6KFY 2023$100.8KFY 2024$48.3KFY 2025$49.9K
$58.5K$49.9K

Free cash flow by year

2021 → 2025

FY 2021$-224.7KFY 2022$-1.9MFY 2023$-1.6MFY 2024$-1.3MFY 2025$-9.2M
-$224.7K-$9.2M

Gross margin by year

2021 → 2025

FY 202139.4%FY 202235.3%FY 202336.3%FY 2024-6.3%FY 2025-1.3%
39.4%-1.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 20-F/A filed Jul 1, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Annual report20-F FiledJul 1, 2026Filing
  • 6-K filingFDA Clearance AnnouncementJun 15, 2026Filing
  • 6-K filingRegulatory UpdateJun 12, 2026Filing
  • 6-K filingAnnual Meeting ResultsMay 14, 2026Filing
  • 6-K filingAnnual General Meeting NoticeApr 28, 2026Filing
  • Annual report20-F FiledApr 27, 2026Filing
  • 6-K filingAnnual General Meeting NoticeApr 21, 2026Filing

Questions

Frequently asked questions

What is Cuprina Holdings (Cayman) Limited Class A Ordinary Shares's market cap?

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) has a market capitalization of $6.7M.

What is CUPR's P/E ratio?

A meaningful P/E ratio is not available for CUPR — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

Are insiders buying CUPR stock?

SEC Form 4 filings show no open-market insider buys at Cuprina Holdings (Cayman) Limited Class A Ordinary Shares in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

CRIS

Curis, Inc.

$7M

APRE

Aprea Therapeutics, Inc.

$6.1M

EVGN

Evogene Ltd.

$6.1M

TCRT

Alaunos Therapeutics, Inc.

$7.4M

XBIO

Xenetic Biosciences, Inc.

$5.9M

CELZ

Creative Medical Technology Holdings, Inc.

$5.9M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.